Compare · BLLN vs HUM
BLLN vs HUM
Side-by-side comparison of BillionToOne Inc. (BLLN) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.80B, about 9.9x BLLN ($4.72B).
- BLLN has been more active in the news (9 items in the past 4 weeks vs 6 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 8 for BLLN).
- Company
- BillionToOne Inc.
- Humana Inc.
- Price
- -
- -
- Market cap
- $4.72B
- $46.80B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 9
- 6
- Recent ratings
- 8
- 25
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest BLLN
- Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
- SVP of Laboratory Operations Ten Bosch John Roderick sold $131,583 worth of shares (1,417 units at $92.86) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 27,884 units (SEC Form 4)
- Chief Technology Officer Tsao David exercised 10,000 shares at a strike of $2.80 and sold $928,600 worth of shares (10,000 units at $92.86) as part of a pre-agreed trading plan (SEC Form 4)
- Chairman and CEO Atay Oguzhan exercised 15,539 shares at a strike of $2.80 and sold $2,331,352 worth of shares (15,539 units at $150.03) as part of a pre-agreed trading plan (SEC Form 4)
- Chairman and CEO Atay Oguzhan exercised 32,500 shares at a strike of $2.80 and sold $6,167,960 worth of shares (45,000 units at $137.07) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
- Chief Product Officer Sakakibara Shan Riku sold $560,840 worth of shares (4,000 units at $140.21) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 200,000 units (SEC Form 4)
- Officer Johnson Nancy Joann sold $1,821,628 worth of shares (14,199 units at $128.29) as part of a pre-agreed trading plan, decreasing direct ownership by 67% to 6,900 units (SEC Form 4)
Latest HUM
- Humana Names Dr. Shantanu Nundy as Chief Medical Officer
- James P. Holland to Join Humana as Medicaid President
- Humana upgraded by Morgan Stanley with a new price target
- Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin
- Director Smith Paul John was granted 544 units of Humana Common (SEC Form 4)
- Director Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)
- Humana upgraded by Evercore ISI with a new price target
- Humana upgraded by Leerink Partners with a new price target
- Humana downgraded by Raymond James
- New insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)